VirTra price target raised to $19 from $14.50 at Roth MKM

Roth MKM raised the firm’s price target on VirTra to $19 from $14.50 and keeps a Buy rating on the shares after its Q4 results. The analyst cites the company’s bookings that “over doubled” from last year and left the backlog growing again, even as order-to-deliver timelines improved. Federal budgeting delays also dragged some Q4 deals, likely positioning VirTra for good bookings in the first half of the year and better growth in the second half, the firm added.